搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Corynebacterium urealyticum 50S ribosomal protein L33 (rpmG) CSB-YP540892DXD
CSB-EP540892DXD
CSB-BP540892DXD
CSB-MP540892DXD
CSB-EP540892DXD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium urealyticum 50S ribosomal protein L32 (rpmF) CSB-YP540893DXD
CSB-EP540893DXD
CSB-BP540893DXD
CSB-MP540893DXD
CSB-EP540893DXD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium urealyticum D-alanine--D-alanine ligase (ddl) CSB-YP540894DXD
CSB-EP540894DXD
CSB-BP540894DXD
CSB-MP540894DXD
CSB-EP540894DXD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium urealyticum 30S ribosomal protein S2 (rpsB) CSB-YP540895DXD
CSB-EP540895DXD
CSB-BP540895DXD
CSB-MP540895DXD
CSB-EP540895DXD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium urealyticum 50S ribosomal protein L21 (rplU) CSB-YP540896DXD
CSB-EP540896DXD
CSB-BP540896DXD
CSB-MP540896DXD
CSB-EP540896DXD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium urealyticum 50S ribosomal protein L20 (rplT) CSB-YP540897DXD
CSB-EP540897DXD
CSB-BP540897DXD
CSB-MP540897DXD
CSB-EP540897DXD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium urealyticum Urease subunit gamma (ureA) CSB-YP540898DXD
CSB-EP540898DXD
CSB-BP540898DXD
CSB-MP540898DXD
CSB-EP540898DXD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium urealyticum Glucosamine-6-phosphate deaminase (nagB) CSB-YP540899DXD
CSB-EP540899DXD
CSB-BP540899DXD
CSB-MP540899DXD
CSB-EP540899DXD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium urealyticum Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC) CSB-YP540900DXD
CSB-EP540900DXD
CSB-BP540900DXD
CSB-MP540900DXD
CSB-EP540900DXD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium urealyticum UPF0133 protein cu1912 (cu1912) CSB-YP540901DXD
CSB-EP540901DXD
CSB-BP540901DXD
CSB-MP540901DXD
CSB-EP540901DXD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cryptomeria japonica 50S ribosomal protein L14, chloroplastic (rpl14) CSB-YP540902DYO
CSB-EP540902DYO
CSB-BP540902DYO
CSB-MP540902DYO
CSB-EP540902DYO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cryptomeria japonica 30S ribosomal protein S18, chloroplastic (rps18) CSB-YP540903DYO
CSB-EP540903DYO
CSB-BP540903DYO
CSB-MP540903DYO
CSB-EP540903DYO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cryptomeria japonica NAD (P)H-quinone oxidoreductase subunit 3, chloroplastic, partial CSB-YP540904DYO1
CSB-EP540904DYO1
CSB-BP540904DYO1
CSB-MP540904DYO1
CSB-EP540904DYO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cryptomeria japonica NAD (P)H-quinone oxidoreductase subunit J, chloroplastic CSB-YP540905DYO
CSB-EP540905DYO
CSB-BP540905DYO
CSB-MP540905DYO
CSB-EP540905DYO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cryptomeria japonica ATP synthase subunit a, chloroplastic (atpI), partial CSB-YP540906DYO1
CSB-EP540906DYO1
CSB-BP540906DYO1
CSB-MP540906DYO1
CSB-EP540906DYO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces griseus subsp. griseus UPF0133 protein SGR_3378 (SGR_3378) CSB-YP540907FOF
CSB-EP540907FOF
CSB-BP540907FOF
CSB-MP540907FOF
CSB-EP540907FOF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces griseus subsp. griseus 50S ribosomal protein L33 3 (rpmG3) CSB-YP540908FOF
CSB-EP540908FOF
CSB-BP540908FOF
CSB-MP540908FOF
CSB-EP540908FOF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces griseus subsp. griseus Serine--tRNA ligase (serS) CSB-YP540909FOF
CSB-EP540909FOF
CSB-BP540909FOF
CSB-MP540909FOF
CSB-EP540909FOF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces griseus subsp. griseus Putative membrane protein insertion efficiency factor (SGR_3697) CSB-YP540910FOF
CSB-EP540910FOF
CSB-BP540910FOF
CSB-MP540910FOF
CSB-EP540910FOF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces griseus subsp. griseus Chromosomal replication initiator protein DnaA (dnaA), partial CSB-YP540911FOF
CSB-EP540911FOF
CSB-BP540911FOF
CSB-MP540911FOF
CSB-EP540911FOF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細(xì)胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>